首页 > 最新文献

Diagnostics最新文献

英文 中文
Drainless Uniportal VATS Wedge Resection for Early Non-Small Cell Lung Cancer: Propensity Analysis of the Effect of Polyglycolic Acid Sheet (NeoveilTM). 无引流单孔VATS楔形切除术治疗早期非小细胞肺癌:聚乙醇酸纤维板(NeoveilTM)效果倾向分析。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-18 DOI: 10.3390/diagnostics14222586
Shuenn-Wen Kuo, Yu-Heng Su, Ke-Cheng Chen

Objectives: Absorbable biomaterials as adjuvant therapy after thoracoscopy are sometimes used in clinical scenarios. With the prevalence of enhanced rapid recovery in thoracic surgery, drainless video-assisted thoracoscopy surgery (VATS) is often adopted by thoracic surgeons. Here, we discuss utilizing an absorbable biomaterial, NeoveilTM (Polyglycolic Acid sheet), for drainless VATS to treat early lung cancer. Methods: This single-center retrospective study was conducted from January 2018 to December 2022 at the National Taiwan University Hospital. We included patients who underwent drainless VATS for early-stage non-small cell lung cancer (NSCLC) in our institute. Propensity analysis was used to minimize selection bias. Outcome measurements were in-hospital stay, operation time, rate of thoracocentesis or chest drain re-insertion, complication rate, and perioperative course. Results: During the study period, 158 lung cancer patients were performed with drainless VATS wedge resection. Among them, Neoveil for stapling line coverage was done in 72 patients, while 86 patients did not receive Neoveil. After propensity analysis, we had 58 patients using Neoveil after drainless thoracoscopic lung resection, compared fairly with 58 patients without Neoveil after the same procedure. The basic characteristics are comparable regarding age, gender, BMI, operation methods, and lung cancer stage after propensity matching. The in-hospital stay (3.2 days in the Neoveil group and 5.6 days in the non-Neoveil group) and operation time (95.7 min in the Neoveil group and 59.3 min in the non-Neoveil group) are significantly different (p = 0.0001). One versus four patients was noted for postoperative conversion chest drainage insertion in each group (p = 0.17). Neither late complications nor recurrence/metastasis occurred in both groups during the following. Conclusions: Based on our 5-year retrospective study, which is balanced with propensity analysis, drainless thoracoscopic surgery treating early lung cancer can be enhanced by Neoveil with faster recovery by reducing the hospital stay, though with longer operation time.

目的:临床上有时会使用可吸收生物材料作为胸腔镜手术后的辅助治疗。随着胸腔镜手术中加强快速恢复的流行,无引流管视频辅助胸腔镜手术(VATS)经常被胸外科医生采用。在此,我们讨论利用可吸收生物材料 NeoveilTM(聚乙二醇酸片)进行无引流VATS手术治疗早期肺癌。方法:这项单中心回顾性研究于 2018 年 1 月至 2022 年 12 月在台湾大学医院进行。我们纳入了在本院接受无引流VATS治疗早期非小细胞肺癌(NSCLC)的患者。我们采用倾向分析来减少选择偏倚。结果测量指标包括住院时间、手术时间、胸腔穿刺术或胸腔引流管再次插入率、并发症发生率和围手术期过程。研究结果研究期间,158 名肺癌患者接受了无引流管 VATS 楔状切除术。其中,72 例患者使用了 Neoveil 进行缝合线覆盖,86 例患者未使用 Neoveil。经过倾向性分析,我们发现有 58 名患者在无引流胸腔镜肺切除术后使用了 Neoveil,而 58 名患者在同样的手术后没有使用 Neoveil,对比结果相当。经过倾向匹配后,患者的年龄、性别、体重指数、手术方式和肺癌分期等基本特征具有可比性。住院时间(Neoveil 组为 3.2 天,非 Neoveil 组为 5.6 天)和手术时间(Neoveil 组为 95.7 分钟,非 Neoveil 组为 59.3 分钟)有显著差异(P = 0.0001)。两组分别有 1 名和 4 名患者术后转为插入胸腔引流管(P = 0.17)。两组患者术后均未出现晚期并发症或复发/转移。结论:根据我们为期 5 年的回顾性研究,并结合倾向分析,Neoveil 无引流胸腔镜手术治疗早期肺癌可缩短住院时间,加快康复,但手术时间较长。
{"title":"Drainless Uniportal VATS Wedge Resection for Early Non-Small Cell Lung Cancer: Propensity Analysis of the Effect of Polyglycolic Acid Sheet (Neoveil<sup>TM</sup>).","authors":"Shuenn-Wen Kuo, Yu-Heng Su, Ke-Cheng Chen","doi":"10.3390/diagnostics14222586","DOIUrl":"https://doi.org/10.3390/diagnostics14222586","url":null,"abstract":"<p><p><b>Objectives:</b> Absorbable biomaterials as adjuvant therapy after thoracoscopy are sometimes used in clinical scenarios. With the prevalence of enhanced rapid recovery in thoracic surgery, drainless video-assisted thoracoscopy surgery (VATS) is often adopted by thoracic surgeons. Here, we discuss utilizing an absorbable biomaterial, Neoveil<sup>TM</sup> (Polyglycolic Acid sheet), for drainless VATS to treat early lung cancer. <b>Methods:</b> This single-center retrospective study was conducted from January 2018 to December 2022 at the National Taiwan University Hospital. We included patients who underwent drainless VATS for early-stage non-small cell lung cancer (NSCLC) in our institute. Propensity analysis was used to minimize selection bias. Outcome measurements were in-hospital stay, operation time, rate of thoracocentesis or chest drain re-insertion, complication rate, and perioperative course. <b>Results:</b> During the study period, 158 lung cancer patients were performed with drainless VATS wedge resection. Among them, Neoveil for stapling line coverage was done in 72 patients, while 86 patients did not receive Neoveil. After propensity analysis, we had 58 patients using Neoveil after drainless thoracoscopic lung resection, compared fairly with 58 patients without Neoveil after the same procedure. The basic characteristics are comparable regarding age, gender, BMI, operation methods, and lung cancer stage after propensity matching. The in-hospital stay (3.2 days in the Neoveil group and 5.6 days in the non-Neoveil group) and operation time (95.7 min in the Neoveil group and 59.3 min in the non-Neoveil group) are significantly different (<i>p</i> = 0.0001). One versus four patients was noted for postoperative conversion chest drainage insertion in each group (<i>p</i> = 0.17). Neither late complications nor recurrence/metastasis occurred in both groups during the following. <b>Conclusions:</b> Based on our 5-year retrospective study, which is balanced with propensity analysis, drainless thoracoscopic surgery treating early lung cancer can be enhanced by Neoveil with faster recovery by reducing the hospital stay, though with longer operation time.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computed Tomography and Magnetic Resonance Enterography: From Protocols to Diagnosis. 计算机断层扫描和磁共振肠造影:从规程到诊断。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-18 DOI: 10.3390/diagnostics14222584
Cesare Maino, Ilaria Mariani, Silvia Girolama Drago, Paolo Niccolò Franco, Teresa Paola Giandola, Francescamaria Donati, Piero Boraschi, Davide Ippolito

Both Magnetic Resonance Enterography (MRE) and Computed Tomography Enterography (CTE) are crucial imaging modalities in the diagnosis and treatment of inflammatory bowel disease (IBD). CTE is often used in acute scenarios, such as when complications (such as abscesses, perforations, or bowel obstructions) are suspected. It can also help determine the degree and extent of pathological processes. Although CTE is rapid, generally accessible, and offers precise images that are useful in emergencies, it does expose patients to ionizing radiation. Nevertheless, MRE is very useful in assessing perianal illness and the small intestine, and it is frequently used in patients who need repeated follow-ups or are pregnant to minimize radiation exposure. Moreover, MRE can demonstrate oedema, fistulas, abscesses, and the thickening of the bowel wall. In addition, MRE offers superior soft tissue contrast resolution without ionizing radiation, which helps identify complications such as fistulas and abscesses. With their respective advantages and disadvantages, both approaches play essential roles in assessing IBD. The primary goal of this review is to provide an overview of the technical specifications, benefits, drawbacks, and imaging findings of CTE and MRE.

磁共振肠造影(MRE)和计算机断层扫描肠造影(CTE)都是诊断和治疗炎症性肠病(IBD)的重要成像方式。CTE 通常用于急性情况,如怀疑有并发症(如脓肿、穿孔或肠梗阻)时。它还有助于确定病理过程的程度和范围。虽然 CTE 快速、易于获取,并能提供在紧急情况下有用的精确图像,但它会使患者暴露于电离辐射中。不过,MRE 对评估肛周疾病和小肠非常有用,而且常用于需要反复随访或怀孕的患者,以尽量减少辐射暴露。此外,MRE 还能显示水肿、瘘管、脓肿和肠壁增厚。此外,MRE 还能在无电离辐射的情况下提供出色的软组织对比分辨率,有助于识别瘘管和脓肿等并发症。这两种方法各有利弊,但在评估 IBD 时都发挥着至关重要的作用。本综述的主要目的是概述 CTE 和 MRE 的技术规格、优点、缺点和成像结果。
{"title":"Computed Tomography and Magnetic Resonance Enterography: From Protocols to Diagnosis.","authors":"Cesare Maino, Ilaria Mariani, Silvia Girolama Drago, Paolo Niccolò Franco, Teresa Paola Giandola, Francescamaria Donati, Piero Boraschi, Davide Ippolito","doi":"10.3390/diagnostics14222584","DOIUrl":"https://doi.org/10.3390/diagnostics14222584","url":null,"abstract":"<p><p>Both Magnetic Resonance Enterography (MRE) and Computed Tomography Enterography (CTE) are crucial imaging modalities in the diagnosis and treatment of inflammatory bowel disease (IBD). CTE is often used in acute scenarios, such as when complications (such as abscesses, perforations, or bowel obstructions) are suspected. It can also help determine the degree and extent of pathological processes. Although CTE is rapid, generally accessible, and offers precise images that are useful in emergencies, it does expose patients to ionizing radiation. Nevertheless, MRE is very useful in assessing perianal illness and the small intestine, and it is frequently used in patients who need repeated follow-ups or are pregnant to minimize radiation exposure. Moreover, MRE can demonstrate oedema, fistulas, abscesses, and the thickening of the bowel wall. In addition, MRE offers superior soft tissue contrast resolution without ionizing radiation, which helps identify complications such as fistulas and abscesses. With their respective advantages and disadvantages, both approaches play essential roles in assessing IBD. The primary goal of this review is to provide an overview of the technical specifications, benefits, drawbacks, and imaging findings of CTE and MRE.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Intravenous Contrast on CT Body Composition Measurements in Patients with Intraductal Papillary Mucinous Neoplasm. 静脉注射对比剂对导管内乳头状黏液性肿瘤患者 CT 体成分测量的影响
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-18 DOI: 10.3390/diagnostics14222593
Ranjit S Chima, Tetiana Glushko, Margaret A Park, Pamela Hodul, Evan W Davis, Katelyn Martin, Aliya Qayyum, Jennifer B Permuth, Daniel Jeong

Background: The effect of differing post-contrast phases on CT body composition measurements is not yet known.

Methods: A fully automated AI-based body composition analysis using DAFS was performed on a retrospective cohort of 278 subjects undergoing pre-treatment triple-phase CT for pancreatic intraductal papillary mucinous neoplasm. The CT contrast phases included noncontrast (NON), arterial (ART), and venous (VEN) phases. The software selected a single axial CT image at mid-L3 on each phase for body compartment segmentation. The areas (cm2) were calculated for skeletal muscle (SM), intermuscular adipose tissue (IMAT), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT). The mean Hounsfield units of skeletal muscle (SMHU) within the segmented regions were calculated. Bland-Altman and Chi Square analyses were performed.

Results: SM-NON had a lower percentage of bias [LOA] than SM-ART, -0.7 [-7.6, 6.2], and SM-VEN, -0.3 [-7.6, 7.0]; VAT-NON had a higher percentage of bias than ART, 3.4 [-18.2, 25.0], and VEN, 5.8 [-15.0, 26.6]; and this value was lower for SAT-NON than ART, -0.4 [-14.9, 14.2], and VEN, -0.5 [-14.3, 13.4]; and higher for IMAT-NON than ART, 5.9 [-17.9, 29.7], and VEN, 9.5 [-17.0, 36.1]. The bias in SMHU NON [LOA] was lower than that in ART, -3.8 HU [-9.8, 2.1], and VEN, -7.8 HU [-14.8, -0.8].

Conclusions: IV contrast affects the voxel HU of fat and muscle, impacting CT analysis of body composition. We noted a relatively smaller bias in the SM, VAT, and SAT areas across the contrast phases. However, SMHU and IMAT experienced larger bias. During threshold risk stratification for CT-based measurements of SMHU and IMAT, the IV contrast phase should be taken into consideration.

背景:不同的对比后阶段对 CT 人体成分测量的影响尚不清楚:不同的后对比阶段对CT身体成分测量的影响尚不清楚:使用 DAFS 对 278 名接受胰腺导管内乳头状粘液瘤治疗前三相 CT 的受检者进行了基于 AI 的全自动身体成分分析。CT 对比相包括非对比相(NON)、动脉相(ART)和静脉相(VEN)。软件在每个相位上选择一张位于 L3 中段的轴向 CT 图像进行体腔分割。计算骨骼肌(SM)、肌间脂肪组织(IMAT)、内脏脂肪组织(VAT)和皮下脂肪组织(SAT)的面积(cm2)。计算了分割区域内骨骼肌的平均 Hounsfield 单位(SMHU)。对结果进行了Bland-Altman和Chi Square分析:SM-NON的偏差百分比[LOA]低于SM-ART(-0.7 [-7.6, 6.2])和SM-VEN(-0.3 [-7.6, 7.0]);VAT-NON的偏差百分比高于ART(3.4 [-18.2, 25.0])和VEN(5.8 [-15.0,26.6];SAT-NON的这一数值低于ART,为-0.4[-14.9,14.2],VEN为-0.5[-14.3,13.4];IMAT-NON的这一数值高于ART,为5.9[-17.9,29.7],VEN为9.5[-17.0,36.1]。SMHU NON [LOA]的偏差低于ART(-3.8 HU [-9.8, 2.1])和VEN(-7.8 HU [-14.8, -0.8]):IV对比度会影响脂肪和肌肉的体素HU,从而影响身体成分的CT分析。我们注意到,在不同对比阶段,SM、VAT 和 SAT 区域的偏差相对较小。但是,SMHU 和 IMAT 的偏差较大。在对基于 CT 的 SMHU 和 IMAT 测量进行阈值风险分层时,应考虑 IV 对比阶段。
{"title":"Effect of Intravenous Contrast on CT Body Composition Measurements in Patients with Intraductal Papillary Mucinous Neoplasm.","authors":"Ranjit S Chima, Tetiana Glushko, Margaret A Park, Pamela Hodul, Evan W Davis, Katelyn Martin, Aliya Qayyum, Jennifer B Permuth, Daniel Jeong","doi":"10.3390/diagnostics14222593","DOIUrl":"https://doi.org/10.3390/diagnostics14222593","url":null,"abstract":"<p><strong>Background: </strong>The effect of differing post-contrast phases on CT body composition measurements is not yet known.</p><p><strong>Methods: </strong>A fully automated AI-based body composition analysis using DAFS was performed on a retrospective cohort of 278 subjects undergoing pre-treatment triple-phase CT for pancreatic intraductal papillary mucinous neoplasm. The CT contrast phases included noncontrast (NON), arterial (ART), and venous (VEN) phases. The software selected a single axial CT image at mid-L3 on each phase for body compartment segmentation. The areas (cm<sup>2</sup>) were calculated for skeletal muscle (SM), intermuscular adipose tissue (IMAT), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT). The mean Hounsfield units of skeletal muscle (SMHU) within the segmented regions were calculated. Bland-Altman and Chi Square analyses were performed.</p><p><strong>Results: </strong>SM-NON had a lower percentage of bias [LOA] than SM-ART, -0.7 [-7.6, 6.2], and SM-VEN, -0.3 [-7.6, 7.0]; VAT-NON had a higher percentage of bias than ART, 3.4 [-18.2, 25.0], and VEN, 5.8 [-15.0, 26.6]; and this value was lower for SAT-NON than ART, -0.4 [-14.9, 14.2], and VEN, -0.5 [-14.3, 13.4]; and higher for IMAT-NON than ART, 5.9 [-17.9, 29.7], and VEN, 9.5 [-17.0, 36.1]. The bias in SMHU NON [LOA] was lower than that in ART, -3.8 HU [-9.8, 2.1], and VEN, -7.8 HU [-14.8, -0.8].</p><p><strong>Conclusions: </strong>IV contrast affects the voxel HU of fat and muscle, impacting CT analysis of body composition. We noted a relatively smaller bias in the SM, VAT, and SAT areas across the contrast phases. However, SMHU and IMAT experienced larger bias. During threshold risk stratification for CT-based measurements of SMHU and IMAT, the IV contrast phase should be taken into consideration.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of Peroral Cholangioscopy in the Initial Endoscopic Retrograde Cholangiopancreatography for Malignant Biliary Strictures. 在恶性胆道狭窄的初始内镜逆行胰胆管造影术中采用口周胆道造影术的可行性。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-18 DOI: 10.3390/diagnostics14222589
Yuichi Suzuki, Tomohiro Ishii, Haruo Miwa, Takeshi Sato, Yoshihiro Goda, Kuniyasu Irie, Kazuya Sugimori, Shin Maeda

Background: Peroral cholangioscopy (POCS) is valuable for assessing malignant biliary strictures; however, biliary drainage prior to POCS often hinders accurate diagnosis. Objectives: This retrospective study aimed to investigate the feasibility of POCS using a newly developed cholangioscope, CHF-B290, during initial endoscopic retrograde cholangiopancreatography (ERCP) for malignant biliary strictures. Methods: This multicenter retrospective study included patients who underwent initial ERCP for malignant biliary strictures at two institutions between January 2018 and March 2022. Patients who underwent initial ERCP with POCS were classified into the POCS group, and those without POCS were classified into the non-POCS group. To prevent post-POCS cholangitis, the original irrigation system for CHF-B290 was used in all POCS examinations. The primary endpoint was the rate of post-ERCP biliary infections, and the secondary endpoints were other ERCP-related complications, including pancreatitis, bleeding, and perforation. Results: Overall, 53 and 94 patients were included in the POCS and non-POCS groups, respectively. For the primary endpoint, the rate of post-ERCP biliary infection was not significantly different between the two groups (1.9% vs. 5.3%, p = 0.42). For the secondary endpoints, no significant differences were observed in the rates of post-ERCP pancreatitis (5.7% vs. 6.4%, p = 1.00) and other ERCP-related complications. The overall complication rate was 9.4% in the POCS group and 13% in the non-POCS group (p = 0.60). Conclusions: POCS during the initial ERCP for malignant biliary strictures is feasible.

背景:口周胆管造影术(POCS)对评估恶性胆道狭窄很有价值;但在 POCS 之前进行胆道引流往往会妨碍准确诊断。研究目的这项回顾性研究旨在探讨在恶性胆道狭窄的初次内镜逆行胰胆管造影术(ERCP)中使用新开发的胆道镜 CHF-B290 进行口周胆道镜检查的可行性。方法:这项多中心回顾性研究纳入了2018年1月至2022年3月期间在两家机构接受初次ERCP治疗恶性胆道狭窄的患者。接受初始ERCP时使用POCS的患者被分为POCS组,未使用POCS的患者被分为非POCS组。为防止POCS后胆管炎,所有POCS检查均使用CHF-B290的原始灌洗系统。主要终点是ERCP术后胆道感染率,次要终点是其他ERCP相关并发症,包括胰腺炎、出血和穿孔。结果:POCS 组和非 POCS 组分别有 53 名和 94 名患者。在主要终点方面,两组ERCP术后胆道感染率无明显差异(1.9% 对 5.3%,P = 0.42)。在次要终点方面,ERCP术后胰腺炎的发生率(5.7% vs. 6.4%,p = 1.00)和其他ERCP相关并发症的发生率无明显差异。POCS组的总并发症发生率为9.4%,非POCS组为13%(P = 0.60)。结论在治疗恶性胆道狭窄的初始ERCP期间进行POCS是可行的。
{"title":"Feasibility of Peroral Cholangioscopy in the Initial Endoscopic Retrograde Cholangiopancreatography for Malignant Biliary Strictures.","authors":"Yuichi Suzuki, Tomohiro Ishii, Haruo Miwa, Takeshi Sato, Yoshihiro Goda, Kuniyasu Irie, Kazuya Sugimori, Shin Maeda","doi":"10.3390/diagnostics14222589","DOIUrl":"https://doi.org/10.3390/diagnostics14222589","url":null,"abstract":"<p><p><b>Background:</b> Peroral cholangioscopy (POCS) is valuable for assessing malignant biliary strictures; however, biliary drainage prior to POCS often hinders accurate diagnosis. <b>Objectives:</b> This retrospective study aimed to investigate the feasibility of POCS using a newly developed cholangioscope, CHF-B290, during initial endoscopic retrograde cholangiopancreatography (ERCP) for malignant biliary strictures. <b>Methods:</b> This multicenter retrospective study included patients who underwent initial ERCP for malignant biliary strictures at two institutions between January 2018 and March 2022. Patients who underwent initial ERCP with POCS were classified into the POCS group, and those without POCS were classified into the non-POCS group. To prevent post-POCS cholangitis, the original irrigation system for CHF-B290 was used in all POCS examinations. The primary endpoint was the rate of post-ERCP biliary infections, and the secondary endpoints were other ERCP-related complications, including pancreatitis, bleeding, and perforation. <b>Results:</b> Overall, 53 and 94 patients were included in the POCS and non-POCS groups, respectively. For the primary endpoint, the rate of post-ERCP biliary infection was not significantly different between the two groups (1.9% vs. 5.3%, <i>p</i> = 0.42). For the secondary endpoints, no significant differences were observed in the rates of post-ERCP pancreatitis (5.7% vs. 6.4%, <i>p</i> = 1.00) and other ERCP-related complications. The overall complication rate was 9.4% in the POCS group and 13% in the non-POCS group (<i>p</i> = 0.60). <b>Conclusions:</b> POCS during the initial ERCP for malignant biliary strictures is feasible.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Four-Dimensional Flow MRI for Cardiovascular Evaluation (4DCarE): A Prospective Non-Inferiority Study of a Rapid Cardiac MRI Exam: Study Protocol and Pilot Analysis. 用于心血管评估的四维血流 MRI (4DCarE):快速心脏磁共振成像检查的前瞻性非劣效性研究:研究方案和试点分析。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-18 DOI: 10.3390/diagnostics14222590
Jiaxing Jason Qin, Mustafa Gok, Alireza Gholipour, Jordan LoPilato, Max Kirkby, Christopher Poole, Paul Smith, Rominder Grover, Stuart M Grieve

Background: Accurate measurements of flow and ventricular volume and function are critical for clinical decision-making in cardiovascular medicine. Cardiac magnetic resonance (CMR) is the current gold standard for ventricular functional evaluation but is relatively expensive and time-consuming, thus limiting the scale of clinical applications. New volumetric acquisition techniques, such as four-dimensional flow (4D-flow) and three-dimensional volumetric cine (3D-cine) MRI, could potentially reduce acquisition time without loss in accuracy; however, this has not been formally tested on a large scale.

Methods: 4DCarE (4D-flow MRI for cardiovascular evaluation) is a prospective, multi-centre study designed to test the non-inferiority of a compressed 20 min exam based on volumetric CMR compared with a conventional CMR exam (45-60 min). The compressed exam utilises 4D-flow together with a single breath-hold 3D-cine to provide a rapid, accurate quantitative assessment of the whole heart function. Outcome measures are (i) flow and chamber volume measurements and (ii) overall functional evaluation. Secondary analyses will explore clinical applications of 4D-flow-derived parameters, including wall shear stress, flow kinetic energy quantification, and vortex analysis in large-scale cohorts. A target of 1200 participants will enter the study across three sites. The analysis will be performed at a single core laboratory site. Pilot Results: We present a pilot analysis of 196 participants comparing flow measurements obtained by 4D-flow and conventional 2D phase contrast, which demonstrated moderate-good consistency in ascending aorta and main pulmonary artery flow measurements between the two techniques. Four-dimensional flow underestimated the flow compared with 2D-PC, by approximately 3 mL/beat in both vessels.

Conclusions: We present the study protocol of a prospective non-inferiority study of a rapid cardiac MRI exam compared with conventional CMR. The pilot analysis supports the continuation of the study.

Study registration: This study is registered with the Australia and New Zealand Clinical Trials Registry (Registry number ACTRN12622000047796, Universal Trial Number: U1111-1270-6509, registered 17 January 2022-Retrospectively registered).

背景:精确测量血流、心室容积和功能对心血管内科的临床决策至关重要。心脏磁共振(CMR)是目前评估心室功能的黄金标准,但相对昂贵且耗时,因此限制了临床应用的规模。方法:4DCarE(用于心血管评估的 4D 流式 MRI)是一项前瞻性多中心研究,旨在测试基于容积式 CMR 的 20 分钟压缩检查与传统 CMR 检查(45-60 分钟)相比是否具有优越性。压缩检查利用 4D 流量和单次屏气 3D cine 对整个心脏功能进行快速、准确的定量评估。结果测量包括:(i) 流量和心腔容积测量;(ii) 整体功能评估。次要分析将探索 4D 流量衍生参数的临床应用,包括大规模队列中的壁剪应力、流动动能量化和涡流分析。三个研究地点将有 1200 名参与者参与研究。分析将在一个核心实验室进行。试验结果:我们对 196 名参与者进行了试验性分析,比较了四维血流和传统二维相位对比所获得的血流测量结果,结果表明两种技术在升主动脉和主肺动脉血流测量结果方面具有中等程度的一致性。与二维相位对比相比,四维血流低估了两支血管的血流,大约低估了 3 毫升/搏动:我们介绍了快速心脏 MRI 检查与传统 CMR 相比非劣效性前瞻性研究的研究方案。试验分析支持继续进行这项研究:本研究已在澳大利亚和新西兰临床试验注册中心注册(注册号:ACTRN12622000047796,通用试验号:U1111-1270-6509):U1111-1270-6509,2022年1月17日注册-回顾注册)。
{"title":"Four-Dimensional Flow MRI for Cardiovascular Evaluation (4DCarE): A Prospective Non-Inferiority Study of a Rapid Cardiac MRI Exam: Study Protocol and Pilot Analysis.","authors":"Jiaxing Jason Qin, Mustafa Gok, Alireza Gholipour, Jordan LoPilato, Max Kirkby, Christopher Poole, Paul Smith, Rominder Grover, Stuart M Grieve","doi":"10.3390/diagnostics14222590","DOIUrl":"https://doi.org/10.3390/diagnostics14222590","url":null,"abstract":"<p><strong>Background: </strong>Accurate measurements of flow and ventricular volume and function are critical for clinical decision-making in cardiovascular medicine. Cardiac magnetic resonance (CMR) is the current gold standard for ventricular functional evaluation but is relatively expensive and time-consuming, thus limiting the scale of clinical applications. New volumetric acquisition techniques, such as four-dimensional flow (4D-flow) and three-dimensional volumetric cine (3D-cine) MRI, could potentially reduce acquisition time without loss in accuracy; however, this has not been formally tested on a large scale.</p><p><strong>Methods: </strong>4DCarE (4D-flow MRI for cardiovascular evaluation) is a prospective, multi-centre study designed to test the non-inferiority of a compressed 20 min exam based on volumetric CMR compared with a conventional CMR exam (45-60 min). The compressed exam utilises 4D-flow together with a single breath-hold 3D-cine to provide a rapid, accurate quantitative assessment of the whole heart function. Outcome measures are (i) flow and chamber volume measurements and (ii) overall functional evaluation. Secondary analyses will explore clinical applications of 4D-flow-derived parameters, including wall shear stress, flow kinetic energy quantification, and vortex analysis in large-scale cohorts. A target of 1200 participants will enter the study across three sites. The analysis will be performed at a single core laboratory site. Pilot Results: We present a pilot analysis of 196 participants comparing flow measurements obtained by 4D-flow and conventional 2D phase contrast, which demonstrated moderate-good consistency in ascending aorta and main pulmonary artery flow measurements between the two techniques. Four-dimensional flow underestimated the flow compared with 2D-PC, by approximately 3 mL/beat in both vessels.</p><p><strong>Conclusions: </strong>We present the study protocol of a prospective non-inferiority study of a rapid cardiac MRI exam compared with conventional CMR. The pilot analysis supports the continuation of the study.</p><p><strong>Study registration: </strong>This study is registered with the Australia and New Zealand Clinical Trials Registry (Registry number ACTRN12622000047796, Universal Trial Number: U1111-1270-6509, registered 17 January 2022-Retrospectively registered).</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of Pre-Procedural Blood Tests in Neuraxial Blocks: A Retrospective Study in High-Risk Patients. 神经阻滞术前血液检测的效用:高风险患者的回顾性研究。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-18 DOI: 10.3390/diagnostics14222588
Sungho Moon, Daeseok Oh

Background/Objectives: The necessity and clinical utility of routine pre-procedural blood tests (PBTs) before neuraxial blockade remain controversial. This study evaluates the effectiveness of PBTs in identifying clinically significant conditions in an outpatient setting. Methods: This single-center retrospective study involved patients who received neuraxial blockades from January 2020 to August 2023. We extracted medical information and laboratory data from the electronic medical records during the pre-procedural period. Through a multivariate regression analysis, we identified patient factors associated with abnormal laboratory results. Results: Advanced age (OR, 1.021; p = 0.026) and a history of cancer (OR, 2.359; p = 0.016) were significantly associated with elevated CRP levels (>0.30 mg/dL). Severe hyperglycemia (≥200 mg/dL) was found in 24 patients (3.88%), with a history of cancer being a strong predictor (OR, 6.764; p < 0.001). No significant abnormalities were observed in PT or PTT. Reduced eGFR (<60 mL/min/1.73 m2) was detected in 8.62% of patients, despite no prior history of renal dysfunction. A multivariate analysis revealed that advanced age, hypertension, cancer, and coronary artery disease were significant predictors of abnormal PBT results, highlighting the importance of selective testing in high-risk patients. Conclusions: Routine PBTs are not universally required for all patients undergoing neuraxial blockade but can provide crucial information in high-risk populations. A selective testing approach based on individual risk factors is recommended to optimize patient safety and resource utilization. Future studies should aim to establish clear guidelines for targeted PBT use.

背景/目的:神经阻滞术前常规血液检查(PBT)的必要性和临床实用性仍存在争议。本研究评估了 PBT 在门诊环境中识别临床重大疾病的有效性。方法:这项单中心回顾性研究涉及 2020 年 1 月至 2023 年 8 月期间接受神经阻滞的患者。我们从电子病历中提取了手术前的医疗信息和实验室数据。通过多变量回归分析,我们确定了与实验室结果异常相关的患者因素。结果显示高龄(OR,1.021;p = 0.026)和癌症病史(OR,2.359;p = 0.016)与 CRP 水平升高(>0.30 mg/dL)显著相关。有 24 名患者(3.88%)出现严重高血糖(≥200 mg/dL),癌症病史是一个很强的预测因素(OR,6.764;p <0.001)。PT 或 PTT 未见明显异常。8.62%的患者检测到 eGFR(2)降低,尽管之前没有肾功能障碍病史。多变量分析显示,高龄、高血压、癌症和冠状动脉疾病是预测 PBT 结果异常的重要因素,这凸显了对高危患者进行选择性检测的重要性。结论:并非所有接受神经阻滞的患者都需要进行常规 PBT,但它能为高危人群提供重要信息。建议采用基于个体风险因素的选择性检测方法,以优化患者安全和资源利用。未来的研究应旨在为有针对性地使用 PBT 制定明确的指导方针。
{"title":"The Utility of Pre-Procedural Blood Tests in Neuraxial Blocks: A Retrospective Study in High-Risk Patients.","authors":"Sungho Moon, Daeseok Oh","doi":"10.3390/diagnostics14222588","DOIUrl":"https://doi.org/10.3390/diagnostics14222588","url":null,"abstract":"<p><p><b>Background/Objectives</b>: The necessity and clinical utility of routine pre-procedural blood tests (PBTs) before neuraxial blockade remain controversial. This study evaluates the effectiveness of PBTs in identifying clinically significant conditions in an outpatient setting. <b>Methods</b>: This single-center retrospective study involved patients who received neuraxial blockades from January 2020 to August 2023. We extracted medical information and laboratory data from the electronic medical records during the pre-procedural period. Through a multivariate regression analysis, we identified patient factors associated with abnormal laboratory results. <b>Results</b>: Advanced age (OR, 1.021; <i>p</i> = 0.026) and a history of cancer (OR, 2.359; <i>p</i> = 0.016) were significantly associated with elevated CRP levels (>0.30 mg/dL). Severe hyperglycemia (≥200 mg/dL) was found in 24 patients (3.88%), with a history of cancer being a strong predictor (OR, 6.764; <i>p</i> < 0.001). No significant abnormalities were observed in PT or PTT. Reduced eGFR (<60 mL/min/1.73 m<sup>2</sup>) was detected in 8.62% of patients, despite no prior history of renal dysfunction. A multivariate analysis revealed that advanced age, hypertension, cancer, and coronary artery disease were significant predictors of abnormal PBT results, highlighting the importance of selective testing in high-risk patients. <b>Conclusions</b>: Routine PBTs are not universally required for all patients undergoing neuraxial blockade but can provide crucial information in high-risk populations. A selective testing approach based on individual risk factors is recommended to optimize patient safety and resource utilization. Future studies should aim to establish clear guidelines for targeted PBT use.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice. IgG4相关疾病分类标准比较分析及临床实践中回顾性队列诊断准确性评估
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-17 DOI: 10.3390/diagnostics14222583
Marta Lopez-Gomez, Patricia Moya-Alvarado, Hye Sang Park, Mar Concepción Martín, Sara Calleja, Helena Codes-Mendez, Berta Magallares, Iván Castellví, Antonio J Barros-Membrilla, Ana Laiz, César Diaz-Torné, Luis Sainz, Julia Bernárdez, Laura Martínez-Martinez, Hèctor Corominas

Introduction: We conducted a comprehensive comparative analysis of the Okazaki, Umehara, and American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria for diagnosing immunoglobulin G4-related disease (IgG4-RD).

Materials and methods: A retrospective study was conducted in a single tertiary hospital, using expert clinical judgment as the gold standard. We compared the diagnostic accuracy of the Okazaki, Umehara, and ACR/EULAR criteria in a cohort of 41 patients with suspected IgG4-RD. We assessed sensitivity, specificity, and positive and negative predictive values for each criterion, and conducted a separate analysis based on four IgG4-RD subtypes.

Results: A total of 30 patients were confirmed to have IgG4-RD and 11 were identified as mimickers. The Umehara criteria demonstrated the highest sensitivity (83.33%), followed by the ACR/EULAR 2019 (66.67%) and Okazaki (60.0%) criteria. All three criteria exhibited 100% specificity, with overall diagnostic accuracy ranging from 70% to 88%. The areas under the curve (AUC) were 0.917 (Umehara), 0.800 (Okazaki), and 0.833 (ACR/EULAR 2019), indicating significant diagnostic effectiveness (p < 0.000). Subtype analysis revealed that the Umehara and ACR/EULAR 2019 criteria were more effective in diagnosing pancreato-hepato-biliary involvement (subtype 1), while the Okazaki and ACR/EULAR 2019 criteria were more effective in diagnosing retroperitoneal fibrosis and/or aortitis (subtype 2).

Conclusions: Our study provides valuable insights into the diagnostic performance of the Okazaki, Umehara, and ACR/EULAR criteria for a cohort of patients with suspected IgG4-RD. The Umehara criterion demonstrated the highest sensitivity, suggesting its potential utility for screening purposes, while all three criteria showed consistent specificity.

简介:我们对冈崎、梅原和美国风湿病学会/欧洲抗风湿病联盟(ACR/EULAR)诊断免疫球蛋白 G4 相关疾病(IgG4-RD)的分类标准进行了全面的比较分析:在一家三级甲等医院进行了一项回顾性研究,以专家临床判断作为金标准。我们在 41 例疑似 IgG4-RD 患者中比较了冈崎标准、梅原标准和 ACR/EULAR 标准的诊断准确性。我们评估了每种标准的敏感性、特异性以及阳性和阴性预测值,并根据四种 IgG4-RD 亚型进行了单独分析:结果:共有 30 名患者被确诊为 IgG4-RD,11 名患者被确定为模仿者。梅原标准的灵敏度最高(83.33%),其次是 ACR/EULAR 2019 标准(66.67%)和冈崎标准(60.0%)。三项标准的特异性均为 100%,总体诊断准确率在 70% 至 88% 之间。曲线下面积(AUC)分别为 0.917(梅原)、0.800(冈崎)和 0.833(ACR/EULAR 2019),表明诊断效果显著(P < 0.000)。亚型分析显示,梅原和 ACR/EULAR 2019 标准对诊断胰肝胆受累(亚型 1)更有效,而冈崎和 ACR/EULAR 2019 标准对诊断腹膜后纤维化和/或主动脉炎(亚型 2)更有效:我们的研究为冈崎、梅原和 ACR/EULAR 标准在疑似 IgG4-RD 患者群中的诊断性能提供了有价值的见解。梅原标准显示出最高的灵敏度,表明其具有潜在的筛查用途,而所有三个标准都显示出一致的特异性。
{"title":"Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice.","authors":"Marta Lopez-Gomez, Patricia Moya-Alvarado, Hye Sang Park, Mar Concepción Martín, Sara Calleja, Helena Codes-Mendez, Berta Magallares, Iván Castellví, Antonio J Barros-Membrilla, Ana Laiz, César Diaz-Torné, Luis Sainz, Julia Bernárdez, Laura Martínez-Martinez, Hèctor Corominas","doi":"10.3390/diagnostics14222583","DOIUrl":"https://doi.org/10.3390/diagnostics14222583","url":null,"abstract":"<p><strong>Introduction: </strong>We conducted a comprehensive comparative analysis of the Okazaki, Umehara, and American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification criteria for diagnosing immunoglobulin G4-related disease (IgG4-RD).</p><p><strong>Materials and methods: </strong>A retrospective study was conducted in a single tertiary hospital, using expert clinical judgment as the gold standard. We compared the diagnostic accuracy of the Okazaki, Umehara, and ACR/EULAR criteria in a cohort of 41 patients with suspected IgG4-RD. We assessed sensitivity, specificity, and positive and negative predictive values for each criterion, and conducted a separate analysis based on four IgG4-RD subtypes.</p><p><strong>Results: </strong>A total of 30 patients were confirmed to have IgG4-RD and 11 were identified as mimickers. The Umehara criteria demonstrated the highest sensitivity (83.33%), followed by the ACR/EULAR 2019 (66.67%) and Okazaki (60.0%) criteria. All three criteria exhibited 100% specificity, with overall diagnostic accuracy ranging from 70% to 88%. The areas under the curve (AUC) were 0.917 (Umehara), 0.800 (Okazaki), and 0.833 (ACR/EULAR 2019), indicating significant diagnostic effectiveness (<i>p</i> < 0.000). Subtype analysis revealed that the Umehara and ACR/EULAR 2019 criteria were more effective in diagnosing pancreato-hepato-biliary involvement (subtype 1), while the Okazaki and ACR/EULAR 2019 criteria were more effective in diagnosing retroperitoneal fibrosis and/or aortitis (subtype 2).</p><p><strong>Conclusions: </strong>Our study provides valuable insights into the diagnostic performance of the Okazaki, Umehara, and ACR/EULAR criteria for a cohort of patients with suspected IgG4-RD. The Umehara criterion demonstrated the highest sensitivity, suggesting its potential utility for screening purposes, while all three criteria showed consistent specificity.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142727008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Magnetic Resonance Imaging in the Evaluation of Functional Impairments in the Right Heart. 心脏磁共振成像在右心功能损伤评估中的应用。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-17 DOI: 10.3390/diagnostics14222581
Andra Negru, Bogdan M Tarcău, Lucia Agoston-Coldea

Cardiac magnetic resonance (cMRI) imaging has recently become essential in cardiology. cMRI is widely recognized as the most reliable imaging technique for assessing the size and performance of the right ventricle. It allows for objective and functional cardiac tissue evaluations. Early in disease progression, cardiac structure and activity decrease subclinically. Late-phase clinically visible signs have been associated with less favourable outcomes. Subclinical alterations ought to be recognized for rapid evaluations and accurate treatment. An increasing amount of evidence supports cMRI deformation parameter quantification. Strain imaging enables cardiologists to assess heart function beyond traditional measurements. Prognostic information for cardiovascular disease patients is obtained through the right ventricle (RV) strain, including information primarily about the left ventricle (LV). Right atrial (RA) function evaluations using RA strain have been promising in recent studies. Therefore, this narrative review aims to present an overview of the data that are currently available for assessing right myocardial strain and biomechanics using cMRI.

心脏磁共振成像(cMRI)是评估右心室大小和性能最可靠的成像技术,已被广泛认可。它可以对心脏组织进行客观的功能评估。在疾病进展的早期,心脏结构和活动会出现亚临床症状。晚期临床可见体征与较差的预后有关。为了快速评估和准确治疗,必须认识到亚临床改变。越来越多的证据支持 cMRI 变形参数量化。应变成像使心脏病专家能够超越传统测量方法评估心脏功能。心血管疾病患者的预后信息可通过右心室(RV)应变获得,包括主要有关左心室(LV)的信息。在最近的研究中,使用右心室应变进行右心房功能评估很有前景。因此,本综述旨在概述目前使用 cMRI 评估右心肌应变和生物力学的可用数据。
{"title":"Cardiac Magnetic Resonance Imaging in the Evaluation of Functional Impairments in the Right Heart.","authors":"Andra Negru, Bogdan M Tarcău, Lucia Agoston-Coldea","doi":"10.3390/diagnostics14222581","DOIUrl":"https://doi.org/10.3390/diagnostics14222581","url":null,"abstract":"<p><p>Cardiac magnetic resonance (cMRI) imaging has recently become essential in cardiology. cMRI is widely recognized as the most reliable imaging technique for assessing the size and performance of the right ventricle. It allows for objective and functional cardiac tissue evaluations. Early in disease progression, cardiac structure and activity decrease subclinically. Late-phase clinically visible signs have been associated with less favourable outcomes. Subclinical alterations ought to be recognized for rapid evaluations and accurate treatment. An increasing amount of evidence supports cMRI deformation parameter quantification. Strain imaging enables cardiologists to assess heart function beyond traditional measurements. Prognostic information for cardiovascular disease patients is obtained through the right ventricle (RV) strain, including information primarily about the left ventricle (LV). Right atrial (RA) function evaluations using RA strain have been promising in recent studies. Therefore, this narrative review aims to present an overview of the data that are currently available for assessing right myocardial strain and biomechanics using cMRI.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Prospective Evaluation of Health Literacy Levels of Pregnant Women in Antenatal Classes: Impact on Delivery Outcomes in Nulliparous and Multiparous Women. 产前班孕妇健康知识水平的前瞻性评估:对单胎和多胎产妇分娩结果的影响。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-17 DOI: 10.3390/diagnostics14222580
Sakine Rahimli Ocakoglu, Zeliha Atak, Ozlem Ozgun Uyaniklar, Gokhan Ocakoglu

Backgrounds/Objectives: Modern technology and educational activities, such as antenatal classes (ACs), increase patient informedness in medicine and improve collaboration between physicians and patients. The present study aimed to evaluate and compare the impact of maternal health literacy (HL) on delivery outcomes between nulliparous and multiparous women who attended antenatal classes. Methods: This prospective study recruited 281 pregnant women who regularly attended ACs, but only 188 who gave birth at our academic tertiary hospital were included in the final analysis. Socio-demographic characteristics, peripartum data (cervical dilatation at the time of admission to the hospital, duration of labor, and mode of delivery), and obstetric interventions (cesarean section (C/S) rate and rate of instrumental vaginal birth and episiotomy) were recorded, and the level of HL was assessed using the European Health Literacy Survey Questionnaire (HLS-EU-Q16). HL levels did not significantly affect peripartum and postpartum outcomes. Results: The study results showed that HL levels did not impact labor duration and newborn Apgar scores (p > 0.05). Patient education levels and employment status affected the peripartum duration of labor (p = 0.048 and p = 0.001, respectively). There were no differences in the HL total score and subscale scores (p > 0.05) between nulliparous and multiparous patients, and the rate of primary C/S was similar in both groups. Conclusions: HL levels did not impact delivery (peripartum) outcomes in pregnant women who attended antenatal classes. However, the primary C/S rate was similar between the nulliparous and multiparous groups, which may indicate that antenatal education services can correct the negative impact of low HL levels on the primary C/S rate.

背景/目标:现代技术和教育活动,如产前课程(ACs),提高了患者对医学的知情程度,改善了医生和患者之间的合作。本研究旨在评估和比较参加产前课程的单胎产妇和多胎产妇的健康知识(HL)对分娩结果的影响。研究方法这项前瞻性研究招募了 281 名定期参加产前课程的孕妇,但只有 188 名在我们的学术性三级医院分娩的孕妇被纳入最终分析。研究记录了孕妇的社会人口特征、围产期数据(入院时宫颈扩张情况、产程和分娩方式)和产科干预措施(剖宫产率、阴道助产率和外阴切开术率),并使用欧洲健康素养调查问卷(HLS-EU-Q16)评估了孕妇的健康素养水平。HL水平对围产期和产后结果没有明显影响。结果研究结果显示,HL水平对产程和新生儿Apgar评分没有影响(P > 0.05)。患者的教育水平和就业状况会影响围产期的产程(分别为 p = 0.048 和 p = 0.001)。单胎和多胎患者的 HL 总分和分量表得分没有差异(P > 0.05),两组患者的初次 C/S 发生率相似。结论HL水平对参加产前课程的孕妇的分娩(围产期)结果没有影响。不过,无痛分娩组和多产组的初次剖宫产率相似,这可能表明产前教育服务可纠正低 HL 水平对初次剖宫产率的负面影响。
{"title":"A Prospective Evaluation of Health Literacy Levels of Pregnant Women in Antenatal Classes: Impact on Delivery Outcomes in Nulliparous and Multiparous Women.","authors":"Sakine Rahimli Ocakoglu, Zeliha Atak, Ozlem Ozgun Uyaniklar, Gokhan Ocakoglu","doi":"10.3390/diagnostics14222580","DOIUrl":"https://doi.org/10.3390/diagnostics14222580","url":null,"abstract":"<p><p><b>Backgrounds/Objectives</b>: Modern technology and educational activities, such as antenatal classes (ACs), increase patient informedness in medicine and improve collaboration between physicians and patients. The present study aimed to evaluate and compare the impact of maternal health literacy (HL) on delivery outcomes between nulliparous and multiparous women who attended antenatal classes. <b>Methods</b>: This prospective study recruited 281 pregnant women who regularly attended ACs, but only 188 who gave birth at our academic tertiary hospital were included in the final analysis. Socio-demographic characteristics, peripartum data (cervical dilatation at the time of admission to the hospital, duration of labor, and mode of delivery), and obstetric interventions (cesarean section (C/S) rate and rate of instrumental vaginal birth and episiotomy) were recorded, and the level of HL was assessed using the European Health Literacy Survey Questionnaire (HLS-EU-Q16). HL levels did not significantly affect peripartum and postpartum outcomes. <b>Results</b>: The study results showed that HL levels did not impact labor duration and newborn Apgar scores (<i>p</i> > 0.05). Patient education levels and employment status affected the peripartum duration of labor (<i>p</i> = 0.048 and <i>p</i> = 0.001, respectively). There were no differences in the HL total score and subscale scores (<i>p</i> > 0.05) between nulliparous and multiparous patients, and the rate of primary C/S was similar in both groups. <b>Conclusions</b>: HL levels did not impact delivery (peripartum) outcomes in pregnant women who attended antenatal classes. However, the primary C/S rate was similar between the nulliparous and multiparous groups, which may indicate that antenatal education services can correct the negative impact of low HL levels on the primary C/S rate.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Surgical Criteria for Intraductal Papillary Mucinous Neoplasm Based on the Age-Adjusted Charlson Comorbidity Index Values and Presence of Solid Component. 基于年龄调整后的夏尔森综合征指数值和是否存在实体成分的导管内乳头状黏液性肿瘤新手术标准
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-17 DOI: 10.3390/diagnostics14222582
Hiroyuki Hasegawa, Mitsuharu Fukasawa, Shinichi Takano, Satoshi Kawakami, Natsuhiko Kuratomi, Shota Harai, Dai Yoshimura, Naoto Imagawa, Tetsuya Okuwaki, Toru Kuno, Yuichiro Suzuki, Takashi Yoshida, Shoji Kobayashi, Mitsuaki Sato, Shinya Maekawa, Naohiro Hosomura, Hiromichi Kawaida, Daisuke Ichikawa, Nobuyuki Enomoto

Objectives: The present study aimed to validate the new international guidelines for IPMN and determine the surgical criteria for patients with IPMN exhibiting high-risk stigmata (HRS). Methods: We enrolled 115 IPMN patients exhibiting HRS who were diagnosed between 2004 and 2021. Of the 115 patients, 79 underwent surgery (surgical group) and 36 did not undergo surgery (non-surgical group). The overall survival (OS) of each group was compared, and multivariate analysis was performed to identify factors associated with OS. Results: There was no significant difference in the estimated 5-year OS in the surgical and non-surgical groups (67% vs. 74%; p = 0.75). The presence of a solid component (SC) (hazard ratio [HR], 6.92; 95% confidence interval [CI], 3.30-14.5) and a high score of age-adjusted Charlson comorbidity index (ACCI) (≥5) (HR, 2.27; 95% CI, 1.11-4.64) were independent predictors of poor OS. In the presence of an SC, the surgical group had a significantly better OS than the non-surgical group (estimated 5-year OS, 38% vs. 18%; p = 0.031). In the absence of an SC, the prognosis of patients with a high ACCI was significantly poorer than those with a low ACCI in the surgical group (estimated 5-year OS, 59% vs. 93%; p = 0.005). Conclusions: An SC and a high ACCI are important prognostic factors in IPMN patients exhibiting HRS. Thus, patients with an SC should undergo surgical resection. However, conservative management may be the optimal treatment in patients without an SC and with a high ACCI.

研究目的本研究旨在验证 IPMN 的新国际指南,并确定表现出高风险征象 (HRS) 的 IPMN 患者的手术标准。方法:我们招募了 115 名在 2004 年至 2021 年期间确诊的表现出 HRS 的 IPMN 患者。在 115 名患者中,79 人接受了手术(手术组),36 人未接受手术(非手术组)。比较两组患者的总生存期(OS),并进行多变量分析以确定与OS相关的因素。结果显示手术组和非手术组的估计5年生存率没有明显差异(67% vs. 74%; p = 0.75)。实性成分(SC)的存在(危险比[HR],6.92;95% 置信区间[CI],3.30-14.5)和年龄调整后查尔森合并症指数(ACCI)的高分(≥5)(HR,2.27;95% CI,1.11-4.64)是不良OS的独立预测因素。在存在 SC 的情况下,手术组的 OS 明显优于非手术组(估计 5 年 OS 为 38% 对 18%;P = 0.031)。在没有 SC 的情况下,手术组 ACCI 高的患者预后明显差于 ACCI 低的患者(估计 5 年 OS,59% 对 93%;P = 0.005)。结论:SC和高ACCI是表现出HRS的IPMN患者的重要预后因素。因此,有 SC 的患者应接受手术切除。然而,对于无 SC 和高 ACCI 的患者,保守治疗可能是最佳治疗方法。
{"title":"New Surgical Criteria for Intraductal Papillary Mucinous Neoplasm Based on the Age-Adjusted Charlson Comorbidity Index Values and Presence of Solid Component.","authors":"Hiroyuki Hasegawa, Mitsuharu Fukasawa, Shinichi Takano, Satoshi Kawakami, Natsuhiko Kuratomi, Shota Harai, Dai Yoshimura, Naoto Imagawa, Tetsuya Okuwaki, Toru Kuno, Yuichiro Suzuki, Takashi Yoshida, Shoji Kobayashi, Mitsuaki Sato, Shinya Maekawa, Naohiro Hosomura, Hiromichi Kawaida, Daisuke Ichikawa, Nobuyuki Enomoto","doi":"10.3390/diagnostics14222582","DOIUrl":"https://doi.org/10.3390/diagnostics14222582","url":null,"abstract":"<p><p><b>Objectives</b>: The present study aimed to validate the new international guidelines for IPMN and determine the surgical criteria for patients with IPMN exhibiting high-risk stigmata (HRS). <b>Methods</b>: We enrolled 115 IPMN patients exhibiting HRS who were diagnosed between 2004 and 2021. Of the 115 patients, 79 underwent surgery (surgical group) and 36 did not undergo surgery (non-surgical group). The overall survival (OS) of each group was compared, and multivariate analysis was performed to identify factors associated with OS. <b>Results</b>: There was no significant difference in the estimated 5-year OS in the surgical and non-surgical groups (67% vs. 74%; <i>p</i> = 0.75). The presence of a solid component (SC) (hazard ratio [HR], 6.92; 95% confidence interval [CI], 3.30-14.5) and a high score of age-adjusted Charlson comorbidity index (ACCI) (≥5) (HR, 2.27; 95% CI, 1.11-4.64) were independent predictors of poor OS. In the presence of an SC, the surgical group had a significantly better OS than the non-surgical group (estimated 5-year OS, 38% vs. 18%; <i>p</i> = 0.031). In the absence of an SC, the prognosis of patients with a high ACCI was significantly poorer than those with a low ACCI in the surgical group (estimated 5-year OS, 59% vs. 93%; <i>p</i> = 0.005). <b>Conclusions</b>: An SC and a high ACCI are important prognostic factors in IPMN patients exhibiting HRS. Thus, patients with an SC should undergo surgical resection. However, conservative management may be the optimal treatment in patients without an SC and with a high ACCI.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"14 22","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142727014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diagnostics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1